| Literature DB >> 31223262 |
Ransi Ann Abraham1, Praween K Agrawal2, Rajib Acharya3, Avina Sarna3, Sowmya Ramesh3, Robert Johnston2, Arjan de Wagt2, Nizamuddin Khan3, Akash Porwal3, Sucheta Banerjee Kurundkar4, Arvind Pandey5, Raghu Pullakhandam6, Krishnapillai Madhavan Nair6, Geeta Trilok Kumar7, H P S Sachdev8, Umesh Kapil9, Renu Saxena9, Sila Deb10, Ajay Khera10, Lakshmy Ramakrishnan1.
Abstract
INTRODUCTION: Preanalytical conditions are critical for blood sample integrity and poses challenge in surveys involving biochemical measurements. A cross sectional study was conducted to assess the stability of select biomarkers at conditions that mimic field situations in surveys.Entities:
Keywords: centrifugation; preanalytical conditions; survey; temperature; time delay
Mesh:
Substances:
Year: 2019 PMID: 31223262 PMCID: PMC6559620 DOI: 10.11613/BM.2019.020708
Source DB: PubMed Journal: Biochem Med (Zagreb) ISSN: 1330-0962 Impact factor: 2.313
Figure 1Flowchart showing details of blood sample collected from all recruited subjects, their distribution into different types of tubes and biochemical analytes tested in samples collected in each type of tube. Three set of SST tubes were taken as most analytes required measurement in serum. HDL - high density lipoprotein cholesterol. LDL - low density lipoprotein cholesterol. TG -triglycerides. sTfRC- soluble transferrin receptor. CRP - C-reactive protein. HbA1c - glycated haemoglobin.
Figure 2Flowchart showing different temperature and time exposure of blood samples collected from group A and B subjects in various types of tubes. Blood collected in various types of tubes were exposed to different temperatures and time. After exposures serum was separated from SST tubes, plasma was separated from fluoride tube, blood from EDTA tube was used directly for haemoglobin and HbA1c measurement and hemolysate was prepared from EDTA blood for folate measurement.
Details of the biochemical analytes studied for stability in blood sample following exposures to different temperature and time conditions, their methodology for analysis and the platforms / instruments used
| Haemoglobin, whole blood | Photometric measurement, Cyanmethemoglobin method | 3 Part Coulter, Siemens, USA |
| C-reactive protein, serum | Immunoturbidimetric | Beckman Coulter, AU 480,USA |
| Total protein, serum | Spectrophotometric, Biuret | Beckman Coulter, AU 680, USA |
| Albumin, serum | Spectrophotometric, BCP - Dye Binding | Beckman Coulter, AU 680, USA |
| Ferritin, serum | Chemiluminescence /Two-SiteSandwich Immunoassay | Advia Centaur XP, Siemens, USA |
| Soluble transferrin receptor, serum | Immunoturbidimetric | Beckman Coulter, AU 480, USA |
| Vitamin A (Retinol), serum | HPLC-reverse phase chromatography | Thermo Finnigan (spectra system) |
| Zinc, serum | Atomic absorption spectrometry+F18:F28, | Shimadzu (AA 7000) |
| Folate, haemolysate | Chemiluminescence / Two-SiteSandwich Immunoassay | Advia Centaur XP, Siemens, USA |
| Vitamin B12, serum | Chemiluminescence / Two-SiteSandwich Immunoassay | Advia Centaur XP, Siemens, USA |
| Vitamin 25 (OH) D, serum | Chemiluminescence / Two-SiteSandwich Immunoassay | Advia Centaur XP, Siemens, USA |
| Glucose, plasma | Spectrophotometric, Hexokinase (UV) | Beckman Coulter, AU 680, USA |
| Glycylated haemoglobin (HbA1C), whole blood | Ion Exchange HPLC | Variant, Biorad, USA |
| Total Cholesterol, serum | Spectrophotometric, Cholesterol Oxidase Esterase Peroxidase | Beckman Coulter, AU 680, USA |
| High Density Lipoprotein Cholesterol (HDL), serum | Spectrophotometric, Direct Measure-Peg/ CHOD | Beckman Coulter, AU 680, USA |
| Low Density Lipoprotein Cholesterol (LDL), serum | Spectrophotometric, Direct Measure/ CHOD | Beckman Coulter, AU 680, USA |
| Triglycerides (TG), serum | Spectrophotometric, Enzymatic Endpoint | Beckman Coulter, AU 680, USA |
| Creatinine, serum | Spectrophotometric, Alkaline Picrate Kinetic (Jaffe’s method) | Beckman Coulter, AU 680, USA |
Analytical coefficient of variation, within subject biological coefficient of variation and total change limit of different biochemical analytes
| HDL- cholesterol | 3.7 | 7.3 | ± 10.9 |
| Albumin | 2.3 | 3.2 | ± 6.6 |
| Cholesterol | 4.2 | 5.95 | ± 12.1 |
| Creatinine | 1.8 | 5.95 | ± 5.9 |
| Glucose | 1.8 | 4.5 | ± 5.6 |
| LDL- cholesterol | 3.5 | 7.8 | ± 10.4 |
| Total Protein | 1.0 | 2.75 | ± 3.0 |
| Triglyceride | 3.5 | 19.9 | ± 13.8 |
| CRP | 2.6 | 42.2 | ± 22.3 |
| Ferritin | 10.4 | 14.2 | ± 29.6 |
| Folate | 6.9 | 24.0 | ± 22.6 |
| Vitamin B12 | 8.8 | 15.0 | ± 25.5 |
| Vitamin D | 4.8 | 11.3 | ± 14.3 |
| HbA1c | 1.2 | 1.9 | ± 3.5 |
| Haemoglobin | 1.5 | 2.85 | ± 4.4 |
| Zinc | 6.9 | 9.4 | ± 19.7 |
| Vitamin A | 3.5 | 19.0 | ± 13.6 |
| sTfR | 3.0 | 3.0 | ± 8.4 |
| HDL - high density lipoprotein. LDL - low density lipoprotein. CRP - C reactive protein. HbA1c - glycylated haemoglobin. sTfR - soluble transferrin receptor. CVb - within-subject biological coefficient of variation, obtained from Ricos ( | |||
Figure 3Mean % deviation in biochemical analytes at different temperatures and time duration of exposure prior to analysis. Figure 3 (a-r) shows the mean % deviation of biochemical analytes from baseline values in blood samples exposed to different temperatures (2-8 °C, RT, 22-30 °C and > 30 °C) for varying lengths of time (6 h, 12 h and 24 h) prior to centrifugation. In each figure, the horizontal lines above and below the mean indicate the TCL values.